Lavie Bio Reports Successful Results for its Bio-Fungicides Programs

Positive results for LAV311 and LAV321 achieved in 2022 in a series of field trials, testing for protection against bunch rot, powdery mildew and blight diseases REHOVOT, Israel, Feb. 28, 2023 /PRNewswire/ — Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and a…

About the Author

has written 20652 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com